Related Experiment Video
Updated: May 5, 2026

07:29
Programmed Electrical Stimulation in Mice
Published on: May 27, 2010
20.3K
Proarrhythmic defects in Timothy syndrome require calmodulin kinase II
William H Thiel1, Biyi Chen, Thomas J Hund
1Vanderbilt University, Nashville, TN, USA.
Circulation
|November 13, 2008
Summary
Timothy syndrome (TS) arrhythmias stem from excessive calcium entry due to a Ca(V)1.2 mutation. This study reveals that CaMKII activation, triggered by the mutation
Area of Science:
- Cardiovascular Physiology
- Molecular Cardiology
- Cardiac Electrophysiology
Background:
- Timothy syndrome (TS) is characterized by excessive cellular calcium (Ca2+) entry and life-threatening arrhythmias.
- The condition arises from a mutation in the cardiac L-type Ca2+ channel (CaV1.2), leading to a loss of normal voltage-dependent inactivation.
- Calmodulin-dependent protein kinase II (CaMKII) activation during cellular Ca2+ overload is implicated in TS arrhythmias.
Purpose of the Study:
- To investigate the role of CaMKII in the proarrhythmic mechanisms of Timothy syndrome.
- To develop and utilize a rat ventricular myocyte model of TS to study CaV1.2 channel function and CaMKII activity.
- To elucidate the upstream events leading to arrhythmia phenotypes in TS.
Main Methods:
- Developed an adult rat ventricular myocyte model of TS (G406R) using lentivirus-mediated transfer of mutated CaV1.2.
- Utilized a dihydropyridine-resistant CaV1.2 mutation (T1066Y) to selectively study exogenous channel function.
- Employed Ca2+ buffering conditions and physiological Ca2+ solutions to assess CaMKII activation and proarrhythmic events.
- Administered CaMKII inhibitory peptide to evaluate its effects on cellular electrophysiology.
- Developed a revised mathematical model incorporating CaMKII-dependent and independent effects.
Main Results:
- TS CaV1.2-expressing myocytes showed loss of voltage-dependent inactivation and increased CaMKII activity in physiological Ca2+.
- Proarrhythmic phenotypes observed included action potential prolongation, increased ICa facilitation, and afterdepolarizations.
- Inhibition of CaMKII reversed ICa facilitation, normalized action potentials, and prevented afterdepolarizations.
- A revised mathematical model was developed to account for CaMKII's role.
Conclusions:
- Loss of voltage-dependent inactivation in TS is an initiating event for arrhythmias.
- CaMKII activation is a critical downstream mediator of TS-associated proarrhythmic phenotypes.
- Understanding this pathway is crucial for developing therapeutic strategies for Timothy syndrome.
Related Concept Videos
Calmodulin-dependent Signaling
5.0K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.0K
Mechanism of Cardiac Arrhythmias
2.7K
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
2.7K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
2.9K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
2.9K
Disturbances in Heart Rhythm
5.3K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
5.3K
Dysrhythmias I: Introduction
730
Dysrhythmias refers to abnormalities in the heart's rhythm. They result from disruptions in the heart's electrical conduction system, which includes the sinoatrial(SA)node, atrioventricular(AV) node, the bundle of His, bundle branches, and Purkinje fibers.Definition and PathophysiologyDysrhythmias result from disorders of impulse formation, impulse conduction, or both. The heart contains specialized cells in the sinoatrial node, atrioventricular node, and the bundle of His and Purkinje fibers...
730
Dysrhythmias VI: Management of Dysrhythmias
597
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
597

